J Lenaerts Selected Research

Rheumatoid Arthritis

11/2022	Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial.
1/2015	Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Lenaerts Research Topics

Disease

2	Rheumatoid Arthritis 11/2022 - 01/2015
2	Axial Spondyloarthritis 01/2014 - 01/2014
1	Rheumatic Diseases (Rheumatism) 01/2015
1	Joint Diseases (Joint Disease) 01/2015

Drug/Important Bio-Agent (IBA)

2	Naproxen (Naprosyn)FDA LinkGeneric 01/2014 - 01/2014
2	Infliximab (Remicade)FDA Link 01/2014 - 01/2014
1	Etanercept (Enbrel)FDA Link 11/2022
1	Antirheumatic Agents (DMARD)IBA 11/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2015
1	GlucocorticoidsIBA 01/2015
1	ametantrone (HAQ)IBA 01/2015
1	Leflunomide (Arava)FDA LinkGeneric 01/2015
1	C-Reactive ProteinIBA 01/2015
1	W 7 (W7)IBA 01/2015
1	Methotrexate (Mexate)FDA LinkGeneric 01/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2014

Therapy/Procedure

3	Therapeutics 01/2015 - 01/2014
1	Remission Induction 01/2015